| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 27-Jun-09 | 28-Mar-09 | | Total Revenue | 124,015 | 167,415 | 160,125 | 146,763 | | Cost of Revenue | 50,953 | 94,729 | 92,569 | 96,252 | | | Gross Profit | 73,062 | 72,686 | 67,556 | 50,511 | | | Operating Expenses | | Research Development | 11,733 | 15,179 | 15,079 | 14,852 | | Selling General and Administrative | 28,678 | 37,439 | 37,482 | 36,256 | | Non Recurring | (24,881) | 26,051 | 597 | 10,791 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 57,532 | (5,983) | 14,398 | (11,388) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 884 | 1,347 |
-
| | Earnings Before Interest And Taxes | 58,954 | (5,099) | 15,745 | (11,388) | | Interest Expense |
-
|
-
|
-
| 415 | | Income Before Tax | 58,954 | (5,099) | 15,745 | (11,803) | | Income Tax Expense | 16,820 | (4,353) | 5,095 | (771) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 42,134 | (746) | 10,650 | (11,032) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,250 | (746) | 10,650 | (11,032) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,250 | ($746) | $10,650 | ($11,032) |
|
1.52% Nasdaq 0.00%
Income Statement
